JP2024096897A5 - - Google Patents

Download PDF

Info

Publication number
JP2024096897A5
JP2024096897A5 JP2024065910A JP2024065910A JP2024096897A5 JP 2024096897 A5 JP2024096897 A5 JP 2024096897A5 JP 2024065910 A JP2024065910 A JP 2024065910A JP 2024065910 A JP2024065910 A JP 2024065910A JP 2024096897 A5 JP2024096897 A5 JP 2024096897A5
Authority
JP
Japan
Prior art keywords
sequence
seq
polypeptide
dyw
editing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024065910A
Other languages
English (en)
Japanese (ja)
Other versions
JP7698351B2 (ja
JP2024096897A (ja
Filing date
Publication date
Priority claimed from PCT/JP2021/014096 external-priority patent/WO2021201198A1/ja
Application filed filed Critical
Publication of JP2024096897A publication Critical patent/JP2024096897A/ja
Priority to JP2025073407A priority Critical patent/JP7698371B1/ja
Publication of JP2024096897A5 publication Critical patent/JP2024096897A5/ja
Priority to JP2025094806A priority patent/JP7897387B2/ja
Application granted granted Critical
Publication of JP7698351B2 publication Critical patent/JP7698351B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024065910A 2020-03-31 2024-04-16 標的rnaを編集する方法 Active JP7698351B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2025073407A JP7698371B1 (ja) 2020-03-31 2025-04-25 標的rnaを編集する方法
JP2025094806A JP7897387B2 (ja) 2020-03-31 2025-06-06 標的rnaを編集する方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2020065065 2020-03-31
JP2020065065 2020-03-31
PCT/JP2021/014096 WO2021201198A1 (ja) 2020-03-31 2021-03-31 標的rnaを編集する方法
JP2022512682A JP7668547B2 (ja) 2020-03-31 2021-03-31 標的rnaを編集する方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022512682A Division JP7668547B2 (ja) 2020-03-31 2021-03-31 標的rnaを編集する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025073407A Division JP7698371B1 (ja) 2020-03-31 2025-04-25 標的rnaを編集する方法

Publications (3)

Publication Number Publication Date
JP2024096897A JP2024096897A (ja) 2024-07-17
JP2024096897A5 true JP2024096897A5 (cg-RX-API-DMAC7.html) 2025-05-02
JP7698351B2 JP7698351B2 (ja) 2025-06-25

Family

ID=77930108

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2022512682A Active JP7668547B2 (ja) 2020-03-31 2021-03-31 標的rnaを編集する方法
JP2024065910A Active JP7698351B2 (ja) 2020-03-31 2024-04-16 標的rnaを編集する方法
JP2025073407A Active JP7698371B1 (ja) 2020-03-31 2025-04-25 標的rnaを編集する方法
JP2025094806A Active JP7897387B2 (ja) 2020-03-31 2025-06-06 標的rnaを編集する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022512682A Active JP7668547B2 (ja) 2020-03-31 2021-03-31 標的rnaを編集する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2025073407A Active JP7698371B1 (ja) 2020-03-31 2025-04-25 標的rnaを編集する方法
JP2025094806A Active JP7897387B2 (ja) 2020-03-31 2025-06-06 標的rnaを編集する方法

Country Status (11)

Country Link
US (1) US20230125942A1 (cg-RX-API-DMAC7.html)
EP (1) EP4130274A4 (cg-RX-API-DMAC7.html)
JP (4) JP7668547B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220165747A (cg-RX-API-DMAC7.html)
CN (1) CN115698296A (cg-RX-API-DMAC7.html)
AU (1) AU2021248204A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022019571A2 (cg-RX-API-DMAC7.html)
CA (1) CA3179365A1 (cg-RX-API-DMAC7.html)
IL (1) IL296955A (cg-RX-API-DMAC7.html)
TW (2) TW202615452A (cg-RX-API-DMAC7.html)
WO (1) WO2021201198A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250281571A1 (en) * 2021-04-30 2025-09-11 Osaka University Therapeutic drug for myotonic dystrophy type 1
WO2023120658A1 (ja) * 2021-12-24 2023-06-29 国立大学法人北陸先端科学技術大学院大学 酵素、複合体、組換えベクター、遺伝性疾患治療薬及びポリヌクレオチド
WO2024249445A2 (en) * 2023-05-26 2024-12-05 The Trustees Of Columbia University In The City Of New York An rna recognition and editing code of pentatricopeptide repeat proteins
CN117384884B (zh) * 2023-11-30 2024-03-08 辉大(上海)生物科技有限公司 IscB多肽及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911501A2 (pt) * 2008-04-29 2015-07-28 Monsanto Technology Llc Genes e usos para melhoramento de plantas.
ES2751126T3 (es) * 2011-10-21 2020-03-30 Univ Kyushu Nat Univ Corp Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo
KR20160007541A (ko) 2013-04-22 2016-01-20 고쿠리쓰다이가쿠호진 규슈다이가쿠 피피알 모티프를 이용한 디앤에이 결합성 단백질 및 그의 이용

Similar Documents

Publication Publication Date Title
Eckert et al. Topology of the transposon Tn10-encoded tetracycline resistance protein within the inner membrane of Escherichia coli
Mahapatra et al. Sequence analysis of the phosphoprotein gene of peste des petits ruminants (PPR) virus: editing of the gene transcript
JP2023506765A5 (cg-RX-API-DMAC7.html)
Zhang et al. Identification and characterization of a regulatory domain on the carboxyl terminus of the measles virus nucleocapsid protein
JP2023082054A5 (cg-RX-API-DMAC7.html)
JP2024520868A5 (cg-RX-API-DMAC7.html)
JP2023179457A5 (cg-RX-API-DMAC7.html)
JP2022519507A5 (cg-RX-API-DMAC7.html)
JP2018138049A5 (cg-RX-API-DMAC7.html)
Schmidt et al. Complete cDNA sequence of chicken vigilin, a novel protein with amplified and evolutionary conserved domains
JP2023528204A5 (cg-RX-API-DMAC7.html)
JP2021505201A5 (cg-RX-API-DMAC7.html)
JP2019536462A5 (cg-RX-API-DMAC7.html)
Blixenkrone-Möller et al. Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript
JP2023529844A5 (cg-RX-API-DMAC7.html)
JP2006523448A5 (cg-RX-API-DMAC7.html)
JPWO2020027010A5 (cg-RX-API-DMAC7.html)
BR112022019571A2 (pt) Método para editar um ácido ribonucleico alvo, domínio dyw, proteína dyw, composição para editar ácido ribonucleico em uma célula eucariótica, ácido nucleico, vetor, e, célula
CA2230111A1 (en) Antisecretory factor peptides regulating pathological permeability changes
US20130273606A1 (en) Secretion yield of a protein of interest by in vivo proteolytic processing of a multimeric precursor
DK200601181A (da) Fiskevaccine
JP2023075230A5 (cg-RX-API-DMAC7.html)
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
JP2005535289A5 (cg-RX-API-DMAC7.html)
CN102190735B (zh) 一种融合蛋白tat-oct4及其编码基因与应用